全外显子组测序与全基因组芯片揭示子宫平滑肌瘤高度异质的基因组景观
该回顾性队列研究对16例新鲜冷冻子宫平滑肌瘤及对应正常肌层组织行全外显子组测序和高分辨率X染色体及全基因组单核苷酸多态性芯片分析,并对153例子宫平滑肌肉瘤检测MED12第2外显子突变。结果显示MED12阴性平滑肌瘤存在Mediator复合体亚基相关拷贝数改变及COL4A6、DCN、AHR等基因突变,约4.6%的平滑肌肉瘤携带MED12第2外显子突变。
要点
- 子宫平滑肌瘤基因组异质性显著,MED12阴性肿瘤存在Mediator复合体亚基相关拷贝数改变。
- MED12阴性平滑肌瘤中鉴定出COL4A6、DCN、AHR及NRG1、ADAM18、HUWE1等基因突变。
- 约4.6%的子宫平滑肌肉瘤携带MED12第2外显子突变,其与分子发病机制的相关性尚不明确。
核心结论
- 子宫平滑肌瘤中存在参与细胞间相互作用和细胞外基质重塑的基因突变,以及涉及Mediator复合体亚基编码基因的基因组畸变。
- 约4.6%的子宫平滑肌肉瘤携带MED12第2外显子突变,但该关联与平滑肌肉瘤分子发病机制的相关性仍未知。
研究设计与样本
- 回顾性队列研究,纳入16例新鲜冷冻子宫平滑肌瘤及对应未受累肌层标本,以及153例子宫平滑肌肉瘤标本,均来自因临床指征行腹式子宫切除术的子宫平滑肌瘤或平滑肌肉瘤女性。
主要发现
- 对已知MED12突变阴性的平滑肌瘤样本行全外显子组测序及高分辨率X染色体和全基因组单核苷酸多态性芯片分析,并与对应肌层比较。
- MED12阴性平滑肌瘤含涉及Mediator复合体亚基MED8、MED18、CDK8及长基因间非蛋白编码RNA340(CASC15)的拷贝数改变,可能影响Mediator结构或转录活性。
- 鉴定出COL4A6、DCN、AHR等与平滑肌瘤发生相关基因的突变,以及NRG1、ADAM18、HUWE1、FBXW4、FBXL13、CAPRIN1等新基因突变。
- 对平滑肌肉瘤标本检测MED12第2外显子突变,约4.6%携带该突变。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine the genomic signatures of human uterine leiomyomas and prevalence of MED12 mutations in human uterine leiomyosarcomas. DESIGN: Retrospective cohort study. SETTING: Not applicable. PATIENT(S): This study included a set of 16 fresh frozen leiomyoma and corresponding unaffected myometrium specimens as well as 153 leiomyosarcomas collected from women diagnosed with uterine leiomyomas or leiomyosarcomas who underwent clinically indicated abdominal hysterectomy. INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): Whole exome sequencing and high-resolution X-chromosome and whole genome single nucleotide polymorphism microarray analyses were performed on leiomyoma samples negative for the known MED12 mutations and compared with their corresponding myometrium. Leiomyosarcoma specimens were examined for exon 2 MED12 mutations to evaluate the frequency of MED12 mutated leiomyosarcomas. RESULT(S): Our results indicate remarkable genomic heterogeneity of leiomyoma lesions. MED12-negative leiomyomas contain copy number alterations involving the Mediator complex subunits such as MED8, MED18, CDK8, and long intergenic nonprotein coding RNA340 (CASC15), which may affect the Mediator architecture and/or its transcriptional activity. We also identified mutations in a number of genes that were implicated in leiomyomagenesis such as COL4A6, DCN, and AHR, as well as novel genes: NRG1, ADAM18, HUWE1, FBXW4, FBXL13, and CAPRIN1. CONCLUSION(S): Mutations in genes implicated in cell-to-cell interactions and remodeling of the extracellular matrix and genomic aberrations involving genes coding for the Mediator complex subunits were identified in uterine leiomyomas. Additionally, we discovered that ∼4.6% of leiomyosarcomas harbored MED12 exon 2 mutations, but the relevance of this association with molecular pathogenesis of leiomyosarcoma remains unknown.
引用
- Yatsenko SA, Mittal P, Wood-Trageser MA, et al. Highly heterogeneous genomic landscape of uterine leiomyomas by whole exome sequencing and genome-wide arrays. Fertil Steril. 2016. PMID: 27889101. doi:10.1016/j.fertnstert.2016.10.035
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。